In light of these Court rulings, at 31 December 2021 and 31 December 2020, the Group has recognised an estimated allowance for GMP equalisation within the IAS 19 valuation for all the UK schemes – comprising £43m for PSPS, £20m for SASPS, and £6m for M&GGPS as at 31 December 2021 (2020: £48m for PSPS, £21m for SASPS and £6m for M&GGPS).